xilis

Xilis is a precision oncology company developing next-generation MicroOrganoSphere (MOS) technologies to guide precision therapy for cancer patients and accelerate drug discovery. Their proprietary MOS technology creates microscale tumors that retain the unique characteristics of a patient's own tumor, allowing for rapid and accurate drug sensitivity testing. This platform enables clinicians to make timely treatment decisions by predicting patient response and guiding optimal therapeutic options.

Xilis' MOS technology is transforming cancer drug development by providing an end-to-end patient-centric solution. Their breakthrough platform enables cost-effective, high-throughput drug candidate screening, pre-clinical assessment of immuno-oncology drugs, personalized assays to determine patient eligibility for clinical trials, and companion diagnostics to guide patients to newly developed treatments. Xilis is collaborating with top academic institutions, pharmaceutical, and biotech companies to bring their innovative technology to the forefront of cancer care.

Xilis is a biotechnology company committed to revolutionizing precision oncology and drug development through its MicroOrganoSphere (MOS) technology. This innovative platform creates microscale tumor models that accurately represent a patient's unique disease state, enabling rapid diagnostics, personalized treatment selection, and efficient drug discovery. By leveraging its MOS platform, Xilis aims to guide clinicians towards the most effective therapies for individual cancer patients, accelerate the development of novel and effective individualized treatment options, and ultimately improve patient outcomes.

Xilis promotes a culture deeply rooted in patient-centricity, emphasizing data-driven decision making and collaboration. They value a mission-focused approach, building for everyone and fostering a sense of community. Integrity is paramount, driving trust both within the organization and with partners. They emphasize servant leadership, empowering team members and prioritizing cross-functional support. This fosters a team-first environment where diverse skill sets work in harmony to deliver transformative results.

Xilis is committed to fostering a diverse, equitable, and inclusive workplace, believing that a variety of perspectives and experiences leads to stronger innovation and better patient outcomes. They strive to build a culture where everyone feels valued, respected, and empowered to contribute their unique talents. This is reflected in their company values, including "Build for everyone, with everyone" and "Team First," which emphasize collaboration and respect for diverse backgrounds and viewpoints. They actively promote a culture of inclusion by providing opportunities for all employees to grow and develop, regardless of their gender, race, ethnicity, sexual orientation, or any other protected characteristic.